NCT04607304View on ClinicalTrials.gov

ABCA2 GIRMS Analytical Validation Clinical Performance Study

NACompletedINTERVENTIONAL

Enrollment

95

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

July 27, 2021

Study Completion Date

July 27, 2021

Conditions

Gastroparesis

Interventions

DEVICE

ABCA2 GIRMS

Two systems (ABCA-C and ABCA-D) with run order randomized

Trial Locations (1)

37027

Cairn Diagnostics, Brentwood

Sponsors

Lead Sponsor

Cairn Diagnostics

All Listed Sponsors

lead

Cairn Diagnostics

INDUSTRY

NCT04607304 - ABCA2 GIRMS Analytical Validation Clinical Performance Study | Biotech Hunter | Biotech Hunter